Kate Antrobus

Kate Antrobus is a global health professional and financier with more than 15 years of experience accelerating access to high-impact medical technologies across emerging markets. She previously held senior roles at Univercells, where she advanced innovative biomanufacturing solutions for vaccines and biologics, and at Lion’s Head Global Partners, advising on blended-finance strategies to strengthen health systems in low- and middle-income countries. Ms. Antrobus was also part of the investment team at Global Health Investment Fund and began her finance career at J.P. Morgan. At Adjuvant, she will support portfolio strategy, partnerships, and scalable industrialization models that expand access to essential health products, with an emphasis on deploying capital in sub-Saharan Africa.